awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26768160-5D618BE3-63BB-49BA-A817-69A65B8FDE9C
Q26768160-5D618BE3-63BB-49BA-A817-69A65B8FDE9C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26768160-5D618BE3-63BB-49BA-A817-69A65B8FDE9C
Onto better TRAILs for cancer treatment
P2860
Q26768160-5D618BE3-63BB-49BA-A817-69A65B8FDE9C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26768160-5D618BE3-63BB-49BA-A817-69A65B8FDE9C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
121ea1a9b87dae5f9d7090a0bbcd7c0232ed5b7d
P2860
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.